Combinations of antiviral agents for treatment of influenza virus infections
Identifieur interne : 002381 ( Main/Exploration ); précédent : 002380; suivant : 002382Combinations of antiviral agents for treatment of influenza virus infections
Auteurs : Frederick G. Hayden [États-Unis]Source :
- Journal of Antimicrobial Chemotherapy [ 0305-7453 ] ; 1986.
Abstract
The rationale for research on the use of combinations of drugs in viral infections includes the identification of drug combinations that allow reduction in individual drug doses and possibly dose-related drug toxicity, potentiation of antiviral activity in infections due to less sensitive viruses, and prevention of the emergence of a drug-resistance. This paper reviews the studies in vitro and in animal models that have addressed these considerations with respect to influenza virus infections.
Url:
DOI: 10.1093/jac/18.Supplement_B.177
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000384
- to stream Istex, to step Curation: 000384
- to stream Istex, to step Checkpoint: 001073
- to stream Main, to step Merge: 002497
- to stream Main, to step Curation: 002381
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Combinations of antiviral agents for treatment of influenza virus infections</title><author wicri:is="90%"><name sortKey="Hayden, Frederick G" sort="Hayden, Frederick G" uniqKey="Hayden F" first="Frederick G." last="Hayden">Frederick G. Hayden</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:EC600A53FCD7F3E72A4C3FDE21BB73886334A220</idno><date when="1986" year="1986">1986</date><idno type="doi">10.1093/jac/18.Supplement_B.177</idno><idno type="url">https://api.istex.fr/ark:/67375/HXZ-05CKFN0N-4/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">000384</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000384</idno><idno type="wicri:Area/Istex/Curation">000384</idno><idno type="wicri:Area/Istex/Checkpoint">001073</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001073</idno><idno type="wicri:doubleKey">0305-7453:1986:Hayden F:combinations:of:antiviral</idno><idno type="wicri:Area/Main/Merge">002497</idno><idno type="wicri:Area/Main/Curation">002381</idno><idno type="wicri:Area/Main/Exploration">002381</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Combinations of antiviral agents for treatment of influenza virus infections</title><author wicri:is="90%"><name sortKey="Hayden, Frederick G" sort="Hayden, Frederick G" uniqKey="Hayden F" first="Frederick G." last="Hayden">Frederick G. Hayden</name><affiliation wicri:level="1"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Departments of Internal Medicine and Pathology, University of Virginia School of Medicine, Charlottesville, Virginia 22908</wicri:regionArea><wicri:noRegion>Virginia 22908</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">Journal of Antimicrobial Chemotherapy</title><title level="j" type="abbrev">J Antimicrob Chemother</title><idno type="ISSN">0305-7453</idno><idno type="eISSN">1460-2091</idno><imprint><publisher>Oxford University Press</publisher><date when="1986-10">1986</date><biblScope unit="vol">18</biblScope><biblScope unit="issue">Supplemet_B</biblScope><biblScope unit="page" from="177">177</biblScope><biblScope unit="page" to="183">183</biblScope></imprint><idno type="ISSN">0305-7453</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0305-7453</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract">The rationale for research on the use of combinations of drugs in viral infections includes the identification of drug combinations that allow reduction in individual drug doses and possibly dose-related drug toxicity, potentiation of antiviral activity in infections due to less sensitive viruses, and prevention of the emergence of a drug-resistance. This paper reviews the studies in vitro and in animal models that have addressed these considerations with respect to influenza virus infections.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country></list><tree><country name="États-Unis"><noRegion><name sortKey="Hayden, Frederick G" sort="Hayden, Frederick G" uniqKey="Hayden F" first="Frederick G." last="Hayden">Frederick G. Hayden</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002381 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002381 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= H2N2V1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:EC600A53FCD7F3E72A4C3FDE21BB73886334A220
|texte= Combinations of antiviral agents for treatment of influenza virus infections
}}
| This area was generated with Dilib version V0.6.33. |  |